Structural basis for nucleotide binding and reaction catalysis in mevalonate diphosphate decarboxylase.
Structural basis for nucleotide binding and reaction catalysis in mevalonate diphosphate decarboxylase.
复制标题
DOI:
10.1021/bi300591x
复制
发表时间:
2012-07-17
期刊:
影响因子:
2.9
通讯作者:
Geisbrecht BV
中科院分区:
文献类型:
--
作者:
Barta ML;McWhorter WJ;Miziorko HM;Geisbrecht BV
Mevalonate diphosphate decarboxylase (MDD) catalyzes the final step of the mevalonate pathway, the Mg++-ATP dependent decarboxylation of mevalonate 5-diphosphate (MVAPP), producing isopentenyl diphosphate (IPP). Synthesis of IPP, an isoprenoid precursor molecule that is a critical intermediate in peptidoglycan and polyisoprenoid biosynthesis, is essential in Gram-positive bacteria (e.g. Staphylococcus, Streptococcus and Enterococcus spp.) and thus the enzymes of the mevalonate pathway are ideal antimicrobial targets. MDD belongs to the GHMP superfamily of small molecule (i.e. metabolite) kinases that have been extensively studied for the past 50 years, yet the crystallization of GHMP kinase ternary complexes has proven difficult. To further our understanding of the catalytic mechanism of GHMP kinases with the purpose of developing broad spectrum antimicrobial agents that target the substrate and nucleotide binding sites, we report the crystal structures of wild-type and mutant (S192A and D283A) ternary complexes of Staphylococcus epidermidis MDD. Comparison of apo-, MVAPP-bound and ternary complexed wild-type MDD provides structural information on the mode of substrate binding and the catalytic mechanism. Structural characterization of ternary complexes of catalytically deficient MDD S192A and D283A (decreased kcat of 103-fold and 105-fold, respectively) provides insight into MDD function. The carboxylate side chain of invariant Asp283 functions as a catalytic base and is essential to the proper orientation of the MVAPP C3-hydroxyl group within the active site funnel. Several MDD amino acids within the conserved phosphate binding loop (‘P-loop’) provide key interactions, stabilizing the nucleotide triphosphoryl moiety. The crystal structures presented here provide a useful foundation for structure-based drug design.
登录
查看更多内容
DOI:
10.1016/0167-4838(87)90170-1
发表时间:
1987-12-18
期刊:
BIOCHIMICA ET BIOPHYSICA ACTA
影响因子:
--
作者:
CHIEW, YE;OSULLIVAN, WJ;LEE, CS
通讯作者:
LEE, CS
影响因子:
2.9
作者:
Andreassi, John L., II;Vetting, Matthew W.;Bilder, Patrick W.;Roderick, Steven L.;Leyh, Thomas S.
通讯作者:
Leyh, Thomas S.
影响因子:
5.8
作者:
Gouet, P;Courcelle, E;Métoz, F
通讯作者:
Métoz, F
DOI:
10.1107/s0907444904019158
发表时间:
2004-12-01
影响因子:
2.2
作者:
Emsley, P;Cowtan, K
通讯作者:
Cowtan, K
影响因子:
4.8
作者:
Barta, Michael L.;Skaff, D. Andrew;Geisbrecht, Brian V.
通讯作者:
Geisbrecht, Brian V.